Endurant Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,362	Closed	-$593K	–	54
2019 Q4	$593K	Sell	19,362 -2,919	-13%	-$89.4K	0.19%	44
2019 Q3	$537K	Buy	+22,281	New	+$537K	0.19%	46
2018 Q1	–	Sell	-17,600	Closed	-$382K	–	70
2017 Q4	$382K	Buy	+17,600	New	+$382K	0.12%	72